Clinical Trial Update: Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety results for NPC-01 in dysmenorrhea have been reported after study completion (sponsor: Nobelpharma). Results were posted on 2014-06-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• NPC-01

Snippet

Sponsor: Nobelpharma | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17